J. Goldman & Co LP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,768,089
+81.2%
159,719
+53.9%
0.06%
+29.2%
Q4 2022$975,720
+165.9%
103,800
-23.1%
0.05%
+166.7%
Q3 2022$367,000
+317.0%
135,000
+950.0%
0.02%
+157.1%
Q3 2019$88,000
-88.8%
12,857
-84.5%
0.01%
-82.9%
Q2 2018$785,00082,6980.04%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$2,613,0006.32%
Opaleye Management Inc. 825,000$14,371,0003.66%
Prosight Management, LP 274,410$4,780,0002.66%
SPHERA FUNDS MANAGEMENT LTD. 859,727$14,976,0001.72%
KNOTT DAVID M 236,600$4,122,0001.34%
Sio Capital Management, LLC 213,252$3,715,0001.28%
NEXTHERA CAPITAL LP 327,730$5,709,0001.09%
EAM Global Investors LLC 115,781$2,017,0000.82%
Nicholas Investment Partners, LP 580,028$10,104,0000.81%
Park West Asset Management LLC 1,269,107$22,108,0000.80%
View complete list of VIKING THERAPEUTICS INC shareholders